AF-ZETA was formed in February 2005 as a result of Zeta Pharmaceuticals acquisition of AF Pharma抯 assets.Both companies have had a long history of importing bulk active and inactive ingredients for the US OTC and prescription pharmaceutical markets. As a result of this merger we offer a broader and more diversified range of APIs to human and veterinary finished dosage manufacturers.

Over the years our focus has been to offer a lower cost alternative to our customer抯 existing sources. With this charter comes the responsibility to present manufacturers who meet cGMP and FDA standards. To facilitate this process we continue to retain the services of FDA consultants to monitor DMF submissions and to conduct pre-FDA inspections, if necessary.

A number of our products are schedule III and IV controlled substances. We are most familiar with the regulatory guidelines and have the necessary DEA permits and warehouse facilities to handle these products.

Our list of products continues to expand. Our multi-lingual staff and combined years of international experience make us a resourceful partner.